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Conclusions This study indicates that fructans induce a significantly lower
intragastric pressure response in the healthy state, when compared to the other
FODMAPs and glucose. Unravelling the sensory, neural and/or hormonal path-
ways involved in the effect of fructans on gastric physiology require further
mechanistic studies. The findings also offer opportunities to identify whether
ingestion of fructans contribute to symptoms associated with impaired gas-
tric accommodation seen in functional GI patients, including irritable bowel
syndrome.
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Introduction and aim The process of aging predisposes to hepatic functio-
nal and structural impairment leading to inflammation – called inflammageing
– and favours non-alcoholic fatty liver disease. Spirulina is a cyanobacterium
within the Oscillatoraceae family, which is used as a food additive. Previous stu-
dies suggest the beneficial effects of Spirulina on immune functions and against
non-alcoholic fatty liver disease, inflammatory disorders, hyperglycaemia and
hypercholesterolaemia in mouse models of metabolic syndrome. The aim of
the present study was to test the potential hepatoprotective effects of Spirulina
extract supplementation in aged mice and to determine whether these effects can
be related to a modulation of the gut microbiota.
Material and methods Male C57Bl6J mice of 3- and 24-months old were
fed a control diet supplemented with or without 5% Spirulina extract (Biores,
Belgium) during 8 weeks.
Results Aged mice exhibited inflammation and oxidative stress in the liver tis-
sue (higher expression of TNF-, IL-6, IL-1beta, MCP-1, CD68, COX-2, CD11c,
TLR4, NADPH oxidase) as compared to mice of 3 months. The supplementation
with Spirulina extract reduced those hepatic inflammatory and oxidative markers
in 24-months mice. Interestingly, the expression of transcription factor involved
in immune system regulation (FoxP3 in T regulatory cells) and the expression of
antimicrobial peptide (Reg3gamma) were upregulated in the ileum of Spirulina-
treated mice. Combination of pyrosequencing and qPCR analyses of the 16S
rRNA gene revealed a decrease in total bacteria and – among specific changes
of gut microbiota composition – an increase in lachnospiraceae population by
Spirulina treatment.
Conclusions Our study shows for the first time that the oral administration of
a cyanobacterium (Spirulina) is able to modulate the gut microbiota, to activate
immune system in the gut, thereby improving hepatic inflammation in aged mice.
Those data allow envisaging new therapeutic tools, based on gut microbes–host
interactions, in the management of systemic diseases, such as non-alcoholic fatty
liver disease.
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Introduction and aim Obesity is a worldwide health problem. Bariatric sur-
gery is becoming one of the most commonly used methods for fighting obesity
and its associated comorbidities. Any type of bariatric surgery techniques may
induce early or late complications that may require a nutritional support. The
aim of this retrospective observational study is to determine the indications
for home parenteral nutrition in patients who developed post-bariatric surgery
complications and the outcome.
Material and methods A specific questionnaire was designed by the ESPEN
HAN/CIF working group and submitted to centres administering home paren-
teral nutrition. This questionnaire included: patients’ demographics, type of
surgery, BMI before surgery and at start of home parenteral nutrition, indica-
tions for home parenteral nutrition (early within 2 months after surgery or late),
including technical and nutritional complications, outcome, parenteral nutrition
regimen, complications. Patients were retrospectively included from January
2008 to June 2014.
Results Eighteen centres answered, covering a total of 2880 patients during
this period, 77 of whom had had bariatric surgery (65 females; mean age
51 ± 7 years); gastric by-pass was performed in 69% of the patients; the mean
BMI was 44.4 and 23.2 before surgery and at start of home parenteral nutrition,
respectively. Indications for home parenteral nutrition were early complications
in 17 cases and late complications in 60 cases. Early complications were mostly
anastomotic leakage/fistula; late complications were hypoalbuminemia, vita-
mins, trace elements deficiencies. Out of 77 patients, 16 needed a surgical
reintervention, 29 were weaned off home parenteral nutrition but six died (causes
unrelated to home parenteral nutrition). During the study period, 58% of the
patients were rehospitalized and central venous complications were observed in
41%. Diabetes mellitus was described in 17 patients out of 77. Home parenteral
nutrition was supportive in 60 patients and exclusive in 17 patients (mean caloric
intake: 23 ± 6 kcal/k BW/day and 1.2 g/kBW/day). Only seven patients out of
77 had professional activities while on home parenteral nutrition.
Conclusions This is the largest observational multicenter study that des-
cribes the use of home parenteral nutrition in patients with post-bariatric surgery
complications. Severe hypoalbuminemia is a major late complication. Rate of
rehospitalisation and CVC infection are high. Home parenteral nutrition may be
a “bridge therapy” before surgical revision. The high mortality rate reflects the
complexity of these cases.
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Introduction and aim Veno-venous extracorporeal membrane oxygenation
(ECMO) is increasingly being used for the treatment of severe acute respiratory
distress syndrome. However, the tolerance to enteral feeds might be impaired
during ECMO for several reasons, including gut hypoperfusion and the frequent
need for sedation and muscle paralysis. The objective of this study was to com-
pare the tolerance to enteral feeding assessed by the gastric residual volum in
patients with severe acute respiratory distress syndrome treated with or without
ECMO, and to search for an association between gastric residual volume and
the amount of vasopressors, sedatives and neuromuscular blocking agents used.
